SCHEMBL7226352

SCHEMBL7226352

COc1cc(NC(=O)Cc2cccc(NC(=O)c3c(-c4c(F)cccc4I)noc3C)c2)cc(OC)c1OC

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.58
LMNA P02545 3/20 0.47
HTT P42858 3/20 0.47
GLA P06280 1/20 0.47
HPGD P15428 1/20 0.47
ATM Q13315 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
ABCB1 P08183 1/20 0.46
ABCC1 P33527 1/20 0.46
KDM4E B2RXH2 1/20 0.45
MAPT P10636 2/20 0.44
TP53 P04637 1/20 0.44
EPAS1 Q99814 1/20 0.44
MET P08581 2/20 0.43
GHSR Q92847 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5776889 0.94 PTGS2 (0.62) PTGS2LMNAHTTGLAHPGD
SCHEMBL5773626 0.89 EPAS1 (0.58) PTGS2LMNAHTTGLAHPGD
SCHEMBL5774938 0.88 PTGS2 (0.54) PTGS2LMNAHTTGLAHPGD
SCHEMBL5778314 0.86 MAPT (0.59) PTGS2LMNAHTTSMN1; SMN2ABCB1
SCHEMBL5777335 0.84 PTGS2 (0.54) PTGS2LMNAHTTGLAHPGD
SCHEMBL5774722 0.82 PTGS2 (0.57) PTGS2LMNAHTTGLAHPGD
SCHEMBL5776665 0.79 PTGS2 (0.54) PTGS2LMNAHTTGLAHPGD
SCHEMBL5775020 0.77 PTGS2 (0.51) PTGS2LMNAHTTGLAHPGD
SCHEMBL5773731 0.76 PTGS2 (0.51) PTGS2LMNAHTTSMN1; SMN2ABCB1
SCHEMBL5770740 0.73 SMN1; SMN2 (0.48) PTGS2LMNAHTTSMN1; SMN2ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6670373-B1 Inhibiting resistant neoplasms where the resistance is conferred by multidrug resistance protein; N-3,4,5-trimethoxyphenyl-3-(3-azidomethyl-isoxazolo(4,5-c) -1,2-dihydro-6-chloro-quinolin-2-on-1-yl)phenylacetamide ELI LILLY AND COMPANY 2003-12-30 US disclosed
EP-1224189-A2 CONDENSED DIHYDROQUINOLINONE DERIVATIVES FOR INHIBITING MRP1 ELI LILLY AND COMPANY (US) 2002-07-24 EP disclosed
WO-2001027116-A2 CONDENSED DIHYDROQUINOLINONE DERIVATIVES FOR INHIBITING MRP1 ELI LILLY AND COMPANY (US) 2001-04-19 WO disclosed